


























Healthcare-seeking strategies among displaced children in
war-ridden northern Uganda: the case of malaria
G. AKELLO-AYEBARE*, J. M. RICHTERS{, A. M. POLDERMAN{ and L. G. VISSER1
*Department of Mental Health, Faculty of Medicine, Gulu University, P.O. Box 166, Gulu,
Uganda
{Department of Public Health and Primary Care, Leiden University Medical Centre, P.O. Box
9600, 2300 RC Leiden, The Netherlands
{Department of Infectious Diseases, Leiden University Medical Centre, P.O. Box 9600, 2300 RC
Leiden, The Netherlands
1Department of Parasitology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC
Leiden, The Netherlands
Received 10 March 2010, Revised 7 June 2010,
Accepted 10 June 2010
A field study was performed to examine suffering and treatment seeking from the perspective of children aged 8–
16 years living in war-affected northern Uganda. Various techniques for collecting qualitative and quantitative data
were used, including a semi-structured questionnaire about illness experiences and medicine use over a 1-month
recall period. The 165 children who were interviewed were attending primary schools for displaced children and/or
commuters’ night shelters.
The children frequently attributed their common febrile ailments to malaria and used a variety of
pharmaceuticals and herbal remedies, as self-medication, for their self-diagnosed malarial episodes. Misdiagnosis
of febrile illnesses by the children (as well as by the local healthcare providers) and frequent misuse of medicines in
the treatment of these illnesses appeared to be very common.
Improvement of the health conditions of these children requires a change of focus. Firstly, children above the age
of 5 years who are not under adult care and who are often no longer welcome in the local hospital’s paediatric ward
need to be accepted at the outpatient clinics currently intended for adults. Secondly, the local diagnostic system
needs to be improved, not only so that malaria can be reliably diagnosed but also so that alternative diagnoses can
be confirmed or rejected, otherwise the current over-consumption of antimalarial drugs may simply be replaced
with an over-consumption of antibiotics.
The most recent armed conflict in northern
Uganda lasted from 1986 to 2007. During this
‘civil war’, up to 2 million people were
displaced (www.un.org/apps/news/story.asp?
NewsID512297&Cr5uganda&Cr1). To pro-
tect people from the wartime dangers, about
800,000 people in this region, mostly
women and children, were moved to so-
called internally-displaced-person (IDP)
camps and ‘protected villages’. Even these
‘protected’ communities suffered, however,
from child abductions, epidemics of infec-
tious disease and abject poverty. Although
epidemiological data on the age-related
morbidity and mortality that occurred in
these communities are lacking, a report by
the international aid organization Médecins
sans Frontières (MSF) indicated that the
children were especially vulnerable to
malaria, diarrhoea-related illnesses, acute
respiratory illnesses and anaemia (www.
msf.or.jp/news/baseline/Baseline.pdf).
The health services in wartime northern
Uganda were mainly provided by the
national Ministry of Health, the main focus
Reprint requests to: G. Akello-Ayebare.
E-mail: akellograce@hotmail.com.
Annals of Tropical Medicine & Parasitology, Vol. 104, No. 5, 369–376 (2010)




























of which has always been the healthcare
needs of children aged ,5 years. Older
children are rarely allowed consultations in
paediatric units and, therefore, when ill,
they must try to access the system for adult
healthcare, where their vulnerability to
infectious diseases and other forms of suf-
fering is, in general, not sufficiently recog-
nised. Children who are not under adult
care, such as those in child-headed house-
holds, are at particular risk of being seriously
neglected in terms of their healthcare. At the
time of the last civil war in northern
Uganda, many such children either lived
permanently in the IDP camps and pro-
tected villages or travelled back and forth
between such settlements and the Gulu
municipality. These children were regularly
exposed to the easily preventable and cur-
able diseases associated with the dire cir-
cumstances in which they were living, while
having little if any access to effective
healthcare.
The present study forms part of a larger
ethnographic investigation designed to
examine the suffering and quest for therapy
of the children caught up in the civil war in
northern Uganda, from the perspective of
the children themselves (Akello, 2010).
Northern Uganda is considered to be a
holo-endemic region for human ma-
laria. The main aim of the present study
was to determine what the children aged 8–
16 years regarded as ‘malaria’ and what they




The fieldwork location was primarily Gulu
municipality and the IDP camps that lay in
the ‘safe zone’ formed from the land that lies
within 7 km of Gulu. The two main fieldwork
periods ran from July 2004–January 2005 and
from July 2005–December 2005 but various
short follow-up visits were made in 2006 and
2007. The first language of the children who
were investigated, and the second language of
the main researcher (G.A.), is Acholi.
Study Population
Over 500 children participated in the study.
Each child investigated was aged 8–16 years
and met at least one of the following three
criteria: lived in child-headed household;
attended a primary school for displaced
children; and was the caregiver for an HIV/
AIDS patient who was either registered in
the Presidents’ Emergency Plan for AIDS
Relief (PEPFAR), at Lacor Hospital, or was
a client of World Vision’s Antiretroviral
Programme. Owing to the high mobility of
the children, few were covered by all of the
various techniques of data collection
employed in the study.
Data Collection
The field study combined qualitative and
quantitative techniques for data collection.
The children were requested to write com-
positions, narrate their experiences, discuss,
list and rank the illnesses that commonly
affected them, and to illustrate, diagramma-
tically, their past illnesses and what medi-
cines they had used in attempts to get better.
In addition, one researcher (G.A.) observed
displaced children at primary schools, chil-
dren’s homes, nurses’ clinics in commuters’
night shelters, the drug shops where children
bought medicines, and the places where
children attended religious services for the
sick. Children were also observed, over a 1-
month period, at four state-aided healthcare
centres: Gulu Regional Referral Hospital
(GRRH), and the Laroo, Laliya and Layibi
Health Centres. The hospital diagnoses that
appeared in children’s registers in the local
hospitals’ outpatients units and children’s
homes were also explored. Interviews about
the diagnoses indicated in these registers
were subsequently conducted with the rele-
vant, local healthcare providers. Occa-
sionally, professional healthcare providers
were interviewed about the frequent diag-
noses of malaria based only on complaints



























of persistent headache (abaa wic), high
body temperature (lyeto) and coldness
(koyo). Accurate estimates of the true
prevalence and incidence of malaria in the
study area could not be made because a
lack of facilities prevented any laboratory-
based confirmation of a suspected case of
the disease. In this text, the use of
quotation marks around the word malaria
indicates that the disease being discussed is
the children’s self-diagnosed ailment, and
not necessarily true malaria.
In order to obtain statistical data, 165
children who attended primary schools for
displaced children and commuters’ night
shelters were interviewed. In each interview,
a semi-structured questionnaire was used to
collect information about the interviewee’s
illness experiences and medicine use over
the previous month. Twenty-four children
were followed over a 6-month period and
participated in several in-depth interviews
and focus-group discussions.
Ethical Considerations
The study protocol was approved by the
Uganda National Council for Science and
Technology. The resident district commis-
sioner, chief administrative officer and
director of health services for Gulu district,
the head teachers of the schools attended by
some of the children investigated, and the
non-governmental organizations that pro-
vided services to displaced children in Gulu
district granted additional permission to
conduct the research. All children who
participated in this study gave their verbal
informed consent. The children who
reported the most harrowing wartime
experiences were referred to the regional
psychiatrist, for review and counselling.
RESULTS
The following narratives, of two of the
children’s experiences with ‘malaria’, indicate
the typical symptoms reported by the study
children and the medications that the children
commonly sought to treat those symptoms.
This is how Ojok, a 14-year-old boy,
wrote about his experience with ‘malaria’:
I used to go and do leja leja [casual farm
labour for money] quite far from home
during school holidays. One day I was
coming back from Lacor village to Kirombe
where I had gone to farm. It rained on me.
By the time I reached home, I had
headache and was feeling very cold. I lit
a fire and sat as close to it as possible but I
was still cold. I bathed with warm water
but the coldness did not stop. I went to
sleep. By the morning time I was still
feeling cold, even when I had covered
myself with two blankets and when I was
sitting under the sun. I used the money I
had earned to go and buy medicines from a
clinic in Kirombe. After swallowing the
chloroquine and Action [paracetamol–
acetyl salicylic acid–caffeine] tablets I
vomited them. Even the next day I vomited
the medicines. I could not drink or eat
anything, not even cold water. I was
drinking only warm water. I bought two
more tablets of chloroquine and Panadol
[paracetamol]. The landlady instructed
me to take the tablets with warm water.
After 2 days I started feeling better though
I was still very weak and dizzy. I had a
slight headache and by the end of the week
I had recovered completely. I have not
fallen sick again for 1 month now.
Acan, a 10-year-old girl, shared her
experiences verbally:
‘It started by feeling koyo [coldness/
shivering or fever] and later with ngok
[vomiting], and I had abaa wic [head-
ache]. I did not come to school that
Tuesday. My older sister, who is 13 years’
old, told me to bathe and go and buy
medicines for malaria. She gave me 100
shillings [equivalent to J0.04 at the time
of the interview] for chloroquine and 50
shillings [J0.02] for Panadol. I brought
two tablets of chloroquine and two



























Panadol. I took them but the next day my
body started itching. My sister bathed me
and took me to Gulu Hospital. By that
time I could not talk and was told to get 10
injections [of quinine] at the hospital.
After 3 days I started feeling better and
decided to go to the well to fetch water, but
when I came back, I was feeling cold, had
a stomach ache and started vomiting
again. I also had diarrhoea. I was taken
back to the hospital by my grandmother.
That time I was given Fansidar [sulfa-
doxine–pyrimethamine] and Panadol
and yat acholi [herbal or Acholi medi-
cines] from home. It was kor muyeme
[mango-tree stems] and lace [unknown
plant species] for malaria. Then I started
feeling better. I was also given orange and
passion-fruit juice to drink.’
Over 400 children wrote about or narrated
their experiences with illnesses (that they
sooner or later diagnosed as ‘malaria’) that
they had suffered from in the previous
month. Children described ‘malaria’ as
malaria madongo (severe malaria), koyo ki
lyeto (coldness and high body temperature)
and/or abaa wic (headache).
When, in the interviews based on semi-
structured questionnaires, 165 children were
asked ‘What illness experience or health
problem affected you in the last month?’,
16 complaints were mentioned (see
Table 1).
The symptoms described by the children,
in conjunction with clinical diagnosis at the
local hospitals, health centres and private
health providers, and supported by the
choice of medicines the children eventually
procured, were reclassified into ‘illnesses’ as
summarized in Table 2. The illness experi-
ences described by the children as malaria
madongo, koyo ki lyeto and/or abaa wic, for
example, were reclassified as ‘malaria’. Since
no gender differences were observed in any
of the ‘malaria’-associated symptoms, data
for the two genders were subsequently
pooled. Table 2 shows that ‘malaria’ was
the most commonly identified ‘illness’,
directly followed by ‘diarrhoea’ and ‘cough
and influenza’.
TABLE 1. The illnesses and health complaints that the 165 interviewed children said they had experienced in the
month prior to the interviews
Illness or symptom No. of interviewees
As reported, in Acholi Translated into English Boys Girls All P*
Aona ki avuru Cough and influenza 76 68 144
Gwinyo Scabies 83 33 116 ,0.05
Tyena lit/wang vu Wounds and injuries 38 57 95 ,0.05
Amwoda ici Stomach ache 22 61 83 ,0.05
Cado Diarrhoea 40 35 75
Cado pii pii Watery diarrhoea 32 30 62
Lyeto Fever 35 24 59
Malaria Malaria 20 21 41
Lit wang Red eye 15 23 38 0.05
Trachoma Trachoma 17 12 29
Koyo Coldness 13 12 25
Abaa wic Headache 11 14 25
Twol okayan Snakebite 17 2 19 ,0.05
Cado marac/Cado remo Bloody diarrhoea 9 4 13
Malaria madongo Severe malaria 5 3 8
Two cimu Epilepsy 1 1 2
Any illness or symptom 434 400 834
*For the inter-gender difference in frequency.



























According to the reports of the 24 children
who were extensively followed-up over
6 months, each of these children suffered a
mean of three episodes of clinically diag-
nosed or self-diagnosed ‘malaria’ during the
follow-up period.
Analysis of medical records during a
month-long observation at the state-aided
out-patient units of the GRRH in Gulu and
the health centres in Laliya, Layibi and
Laroo showed that 70% of the children aged
8–16 years who presented at these institu-
tions were diagnosed as having malaria. All
of these diagnoses were clinical and none
was confirmed parasitologically.
In response to an open-ended question
about the drugs that the 165 interviewed
children had used in the previous month, 19
different drugs or drug combinations were
mentioned (Table 3). Together, the 165
interviewees had used drugs on 1571 occa-
sions in the previous month. The exact
identity of the drugs used was not always
clear and this was particularly the case for
the antibiotics, with many children only able
to describe the appearance of the antibiotic
capsules they had used. In some cases,
however, with the help of three pharmacists
in Gulu, the probable active ingredients
could be identified from the colour of the
capsules. Identification of the drugs used for
‘malaria’ was more straightforward: white
tablets of chloroquine were bought from
many different vendors and recognised by
their bitter taste; sulfadoxine–pyrimetha-
mine was the only other antimalarial drug
available from drug vendors and markets, as
tablets of FansidarH (F. Hoffmann–La
Roche, Basel, Switzerland); and quinine
was only received by injection and by
children who, although believed to have
malaria, had not responded to treatment
with chloroquine or sulfadoxine–pyrimetha-
mine. Quinine was bought from drug
vendors or at hospital pharmacies. More
often than not, whether they had bought or
had been given the drugs, the children took
an incomplete treatment course (often just a
single tablet or capsule). The artemether–
lumefantine (CoartemH; Novartis, Basel,
Switzerland) and other artemisinin-based
drugs that, at the time of the present study,
were recommended for malaria treatment
by the Ugandan Ministry of Health were
never mentioned by any of the children.
The children had purchased the pharma-
ceutical drugs that they had used from ‘drug
shops’ (29%), clinics (27%), hospitals
(21%), and undetermined sources that were
often far away (23%). Apart from these
drugs, herbal medicines were frequently
used, more frequently by the boys than by
the girls. In the month prior to the inter-
views, the 165 interviewees reportedly used
TABLE 2. The results of reclassifying the results shown
in Table 1 into eight main categories of illness among the
165 interviewees
Illness
No. and (%) of the
reported episodes of illness
Malaria 158 (19)
Diarrhoea 150 (18)
Cough and influenza 144 (17)
Scabies 116 (14)
Wounds and injuries 95 (11)
Stomach ache 83 (10)
Eye infection 67 (8)
Other 21 (3)
Any 834 (100)
TABLE 3. The reported frequencies of drug use among
the 165 interviewed children, in the month prior to the
interviews










*PanadolTM (i.e. paracetamol; GlaxoSmithKline,
Brentford, U.K.) or Action (i.e. paracetamol–acetyl
salicylic acid–caffeine; Beta Healthcare International,
Nairobi).



























herbal medicines (mango roots and bark,
pawpaw leaves, garlic, banana sap, neem
leaves, and guava leaves and bark) a total of
595 times.
Drugs to alleviate the signs of ‘malaria’
included antimalarials (226) and antipyretics
(245), with these two types of drugs often
taken together (Table 4). No reliable infor-
mation on the doses used could be collected.
Of all the drugs bought or received by
the interviewees in the month prior to the
interviews, 30% were used to alleviate the
symptoms of ‘malaria’.
DISCUSSION
According to MSF, malaria is the main cause
of human morbidity in northern Uganda,
both in the population as a whole and among
children aged ,5 years, accounting for 47%
and 51% of all episodes of illness in these two
groups, respectively (www.msf.or.jp/news/
baseline/Baseline.pdf). Although the human
malaria in the Gulu area should probably be
characterised as holo-endemic (Prugger et al.,
2008), there are few reliable data of relevance.
One of the main findings from the narra-
tives recorded in the present study is that the
children investigated considered ‘malaria’ as
the major cause of morbidity and took refuge
in extensive self-medication to treat this
ailment. Elsewhere in Africa, malaria tends
to be heavily over-diagnosed in clinics and
dispensaries where sound diagnostic facilities
are lacking or underutilized (Amexo et al.,
2004). A similar level of over-reporting is
likely to have taken place among the dis-
placed children who participated in the
present study. The incidence of ‘malaria’
reported by the 24 children who were the
respondents in several in-depth interviews
over half a year — a mean of three episodes/6-
month period — seems exceptionally high
(and probably far too high to be a believable
estimate of the true incidence) for a pre-
sumably semi-immune population of chil-
dren aged 8–16 years living in an area with
holo-endemic malaria (Reyburn et al., 2005).
Although the children investigated were not
part of a stable, well-settled population, many
of them having moved into their present
place of residence from elsewhere, most
would have lived in malarious areas all of
their lives. Unfortunately, a self-diagnosis or
clinical diagnosis of malaria is probably the
‘easy option’ in an area where the facilities for
making a reliable alternative diagnosis are
absent or very scarce. The perceived link
between fever/headaches/vomiting and ma-
laria, the potential severity of the disease, its
commonness, and its treatability with rela-
tively cheap drugs that are available in even
the most basic of the local drug shops
together lead to an exuberant claim for a
‘pole position’ for malaria, as the cause of
misery and disease. The true prevalence of
malaria and the degree of over-reporting, in
the present study area and in many other
endemic areas, need to be established using
parasitological or molecular methods.
Although the consumption of one or two
tablets of chloroquine or sulfadoxine–pyri-
methamine is unlikely to result in the
effective treatment of malaria, it may give
some symptomatic relief, especially from
fever. Children who take such small doses
of antimalarial drugs may therefore still
consider the treatment as ‘helpful’ or, even,
‘effective’. Data to assess the merits of
incomplete chloroquine or sulfadoxine–
pyrimethamine treatments are lacking. Even
complete courses of treatment with chlor-
oquine or sulfadoxine–pyrimethamine may
be ineffective in the study area because of
TABLE 4. Frequencies of drug use for the manage-
ment of ‘malaria’ within a 1-month recall period, as
reported by the 165 interviewed children




































parasite resistance but, again, the relevant
data are lacking. The fairly frequent men-
tioning of malaria madongo in the children’s
narratives — indicating cases of malaria
who did not respond to chloroquine or
sulfadoxine–pyrimethamine — is perhaps
an indication that non-responsiveness to the
commonest antimalarial drugs in the study
area is a frequent event. If parasite resistance
is already common, there is probably no great
need to reduce the mis-use of chloroquine or
sulfadoxine–pyrimethamine, in the treatment
of children who do not really have malaria, as
a way of slowing the development of such
resistance (Francis et al., 2006).
Children suffering from malaria require
effective antimalarial treatment. Artemisinin-
based combination therapies (ACT), which
have been shown to be highly effective in
reducing malaria-related mortality and mor-
bidity in numerous countries (Ogbonna and
Uneke, 2008), would probably be useful
among the children of Uganda, especially in
areas where the effectiveness of chloroquine
and sulfadoxine–pyrimethamine are dwind-
ling. ACT tend to be relatively expensive,
however, making the accurate diagnosis
of malaria (and the avoidance of over-
treatment) even more important.
The pragmatism of the children investi-
gated in the present study — in their quest
for therapy and resolution of their physical
(and mental) problems in a harsh and
miserable environment — was an essential
part of their survival. The placing of an
erroneous label of ‘malaria’ on too many of
their episodes of illness obscures, however,
the real causes of much of their poor health.
The inadequacy of the existing healthcare
system, to arrive at reliable alternative
diagnoses, encouraged the children towards
inaccurate self-diagnosis and, consequently,
to ineffective treatment.
What, then, are the measures needed to
support and improve the children’s strate-
gies for improving their health? A solid set of
measures to reduce the risk of getting
malaria, such as the provision of impreg-
nated bednets and indoor residual spraying,
should probably be promoted but, if much
of the ‘malaria’ among the children is not
really malaria, it may not trigger a dramatic
reduction in morbidity. Improvements in
the functioning and affordability of the local
health services, including improvements in
the diagnostic services for malaria and the
other major causes of illness, would perhaps
be more beneficial, especially if accurate
diagnosis can be combined with appropriate
treatment for each disease.
The availability of antimalarial and other
drugs from the private sector creates an
opportunity for the children in and around
Gulu to cope actively with the health pro-
blems that they are facing. Unfortunately, in
the absence of easy access to professional
healthcare providers, the children often have
to use a trial-and-error approach involving
both self-diagnosis and self-medication. An
important fraction of the drugs sold by the
private sector, in small pharmacies and
markets, is likely to be of a poor quality and
ineffective (Taylor et al., 2006). Even if the
drugs that the children obtain are effective, the
dosages that they use are mostly too low to
guide the children effectively in learning to use
the right drugs (Taylor et al., 2006). In
addition, doses that are too low to be effective
promote the development of resistance in the
target pathogens. This holds true not only for
the antimalarials but also for the antibiotics. If
the local diagnostic system does not improve,
so that malaria can be reliably diagnosed and
the alternative diagnoses can be confirmed or
rejected, the current over-consumption of
antimalarial drugs may simply be replaced
with an over-consumption of antibiotics.
Since the peace negotiations ended the
civil war in northern Uganda, many of the
displaced people have returned to their
villages. Most of the displaced children
who live in child-headed households and
most of the other children who have to fend
for themselves have, however, been forced
to stay in the IDP camps, as the care
structures that would normally be provided
by the children’s extended families and
home communities have been destroyed. A



























very first step to improve the prospects for
better health among the displaced children
aged 8–16 years is the recognition of the
special position of such children, who are in
charge of their own health and, often, that of
their younger brothers and sisters. Remark-
ably, one in every four households encoun-
tered in the present study was headed by a
child aged 10–15 years (data not shown)
who was responsible for two to eight family
members. The present observations have
policy implications for the provision of, and
access to, healthcare services for children
who have to fend for themselves, not only in
Uganda but also in many other low-income
countries. Sadly, armed conflicts and the
HIV/AIDS pandemic are increasing the
numbers of child-headed households in
many areas of the world.
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